Clinical Research Directory
Browse clinical research sites, groups, and studies.
Testing Gene PilotLX With Latinx Cancer Patients
Sponsor: Fox Chase Cancer Center
Summary
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Official title: Testing the Efficacy of an eHealth Decision Support Tool to Help Latinx Cancer Patients Make Informed Decisions About Tumor Genomic Testing
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
232
Start Date
2025-05-30
Completion Date
2027-12-31
Last Updated
2025-07-03
Healthy Volunteers
No
Conditions
Interventions
Gene PilotLX
eHealth decision making tool regarding tumor genomic profiling
Locations (4)
MD Anderson Cancer Center at Cooper
Camden, New Jersey, United States
Herbert Irving Comprehensive Cancer Center
New York, New York, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States